Middle East and Africa Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, DepoFoam Liposome Technology, and Lysolipid Thermally Sensitive Liposome (LTSL) Technology); Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, and Photodynamic Therapy), and Country
BMI RD
Middle East and Africa Liposome Drug Delivery Market Forecast to 2027- COVID -19 Impact and Regional Analysis- by Product Type (Liposomal doxorubicin, Liposomal paclitaxel, Liposomal Amphotericin B, Others); Technology (Stealth liposome technology, Non- PEGylated liposome technology, DepoFoam Liposome Technology, Lysolipid Thermally Sensitive Liposome Technology); Application (Fungal diseases, Cancer therapy, pain management, Viral Vaccine), and Country
Pages: 125
Market Introduction
The Liposome are novel drug delivery system (NDDS), they are vesicular structures consisting of bilayers which form spontaneously when phospholipids are disappeared in water. They are microscopic vesicles in which an aqueous volume is entirely enclosed by a membrane composed of lipid bilayers.
Get more information on this report :
Market Overview and Dynamics
The Middle East and Africa Liposome Drug Delivery market is expected to reach US$ 327.97 million by 2027 from US$ 162.83 million in 2019. The market is anticipated to grow with a CAGR of 9.3 % from 2019 to 2027. Increasing Prevalence of chronic diseases, increasing demand for non-invasive drug delivery system along with rising R&D expenditures by pharmaceutical companies are some of the driving force of the market. Whereas, high cost associated with development of Non-invasive drug delivery system is about to hinder the market growth during forecast period.
Key Market Segments
In The liposome drug delivery market is mainly segmented on the basis of products, technology and applications. The products are liposomal doxorubicin, liposomal Paclitaxel. On basis of technology it is segmented as stealth liposome technology, Depofoam liposome technology and others. And the final segmentation is on the application such as its usage in cancer therapy, fungal diseases, and pain management.
Major Sources and Companies Listed
Some of the major primary and secondary sources for Liposome drug delivery market included in the report are Food and Drug Administration (FDA), World health Organization (WHO) and others.
Reasons to buy the report
· To understand the Middle East and Africa liposome drug delivery market landscape and identify market segments that are most likely to guarantee a strong return
· Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa liposome drug delivery market
· Efficiently plan M&A and partnership deals in liposome drug delivery market by identifying market segments with the most promising probable sales
· Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East and Africa liposome drug delivery market
· Obtain market revenue forecast for market by various segments from 2019 to 2027 in Middle East and Africa region
MIDDLE EAST AND AFRICA LIPOSOME DRUG DELIVERY MARKET SEGMENTATION
By Product
· Liposomal doxurubicin
· Liposomal Paclitaxel
· Liposomal Amphotericin B
· Others
By Technology
· Stealth liposome technology
· Depofoam liposome technology
· Non-PEGylated liposome Technology
· Lysolipid thermally Sensitive Liposome Technology
By Application
• Fungal diseases
· Cancer therapy
· Pain management
· Viral vaccines
· Photodynamic Therapy
By Country
· South Africa
· Saudi Arabia
· UAE
Company Profiles
· Takeda pharmaceutical company
· Novartis AG
· Ipsen pharma
· Celsion Inc
· Luye pharma group
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Liposome Drug Delivery Market – By Product
1.3.2 Middle East and Africa Liposome Drug Delivery Market – By Technology
1.3.3 Middle East and Africa Liposome Drug Delivery Market – By Application
1.3.4 Middle East and Africa Liposome Drug Delivery Market – By Geography
2. Middle East and Africa Liposome Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Liposome Drug Delivery Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Liposome Drug Delivery Market - Middle East and Africa PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Liposome Drug Delivery Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising prevalence of Chronic Diseases
5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Cost Involved in Development of Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
5.4 Future Trends
5.4.1 Increasing Popularity of Liposomes in Drug Delivery
5.5 Impact Analysis
6. Liposome Drug Delivery Market – Middle East and Africa Analysis
6.1 Middle East and Africa Liposome Drug Delivery Market Revenue Forecasts and Analysis
7. Middle East and Africa Liposome Drug Delivery Market Analysis and Forecasts To 2027 – By Product Overview
7.1 Middle East and Africa Liposome Drug Delivery Market, By Product Type 2019 & 2027 (%)
7.1.1 Middle East and Africa Liposome Drug Delivery Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)
7.2 Liposomal Doxurubicin
7.2.1 Overview
7.2.2 Middle East and Africa Liposome Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.3 Liposomal Paclitaxel
7.3.1 Middle East and Africa Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Liposomal Amphotericin B
7.4.1 overview
7.4.2 Middle East and Africa Liposomal Amphotericin B forecast and market revenue
7.5 Others
7.5.1 overview
7.5.2 Middle East and Africa Other Liposome Drug Delivery Market overview and forecast to 2027
8. Middle East and Africa Liposome Drug Delivery Market – By Technology
8.1 Overview
8.2 Middle East and Africa Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
8.3 Stealth Liposome Technology
8.3.1 Overview
8.3.2 Middle East and Africa Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Non-PEGylated Liposome Technology
8.4.1 Overview
8.4.2 Middle East and Africa Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 DepoFoam Liposome Technology
8.5.1 Overview
8.5.2 Middle East and Africa DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
8.6.1 Overview
8.6.2 Middle East and Africa Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. Middle East and Africa Liposome Drug Delivery Market – By Application
9.1 Overview
9.2 Middle East and Africa Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
9.3 Fungal Diseases
9.3.1 Overview
9.3.2 Fungal Diseases: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Cancer Therapy
9.4.1 Overview
9.4.2 Cancer Therapy: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Pain Management
9.5.1 Overview
9.5.2 Pain Management: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Viral Vaccine
9.6.1 Overview
9.6.2 Viral Vaccine: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Photodynamic Therapy
9.7.1 Overview
9.7.2 Photodynamic Therapy: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
10. Middle East and Africa Liposome Drug Delivery Market – Geographic Analysis
10.1 Middle East and Africa : Liposome Drug Delivery Market
10.1.1 Overview
10.1.2 Middle East and Africa : Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 Middle East and Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.4 Middle East and Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.5 Middle East and Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.6 Middle East and Africa : Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.1.7 Saudi Arabia : Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Saudi Arabia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Saudi Arabia: Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Saudi Arabia: Liposome Drug Delivery market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Saudi Arabia: Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.8 South Africa : Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 South Africa: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 South Africa :Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 South Africa: Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 South Africa: Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9 UAE: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 UAE: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 UAE: Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 UAE: Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 UAE: Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic On Middle East and Africa Liposome Drug Delivery Market
11.1 Middle East and Africa : Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Takeda Pharmaceutical Company Limited
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.3 Novartis AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.5 Luye Pharma Group
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson & Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Ipsen Pharma
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Word Index
LIST OF TABLES
Table 1. R&D Investments by major pharmaceutical companies
Table 2. Middle East and Africa Liposome Drug Delivery Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)
Table 3. Middle East and Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 4. Middle East and Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 5. Middle East and Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. Saudi Arabia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 7. Saudi Arabia Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 8. Saudi Arabia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. South Africa Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Saudi Africa Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 11. South Africa Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. UAE Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 13. UAE Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 14. UAE Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. List of Abbreviation
LIST OF FIGURES
Figure 1. Liposome Drug Delivery Market Segmentation
Figure 2. Middle East and Africa Liposome Drug Delivery Segmentation : By Region
Figure 3. Middle East and Africa Liposome Drug Delivery Market Overview;
Figure 4. Others Segment Held Largest Share of Product Type in Liposome Drug Delivery Market
Figure 5. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period.
Figure 6. Liposome Drug Delivery Market - Middle East and Africa PEST Analysis
Figure 7. Middle East and Africa Liposome Drug Delivery Market Impact Analysis of Driver and Restraints
Figure 8. Middle East and Africa Liposome Drug Delivery Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Middle East and Africa Liposome Drug Deliverys Market, By Product Type 2019 & 2027 (%)
Figure 10. Middle East and Africa Liposomal Doxurubicin Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Middle East and Africa Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Middle East and Africa Liposomal Amphotericin B market revenue and forecast to 2027
Figure 13. Middle East and Africa Other Liposome Drug Delivery Market overview and forecast to 2027
Figure 14. Middle East and Africa Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
Figure 15. Middle East and Africa Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Middle East and Africa Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Middle East and Africa DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Middle East and Africa Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Middle East and Africa Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
Figure 20. Fungal Diseases: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cancer Therapy: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Pain Management: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Viral Vaccine: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Photodynamic Therapy: Middle East and Africa Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Middle East and Africa : Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. Middle East and Africa Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 27. Middle East and Africa : Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 28. Saudi Arabia : Liposome Drug Delivery market – Revenue and Forecast to 2027 (USD Million)
Figure 29. South Africa : Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. UAE : Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of COVID-19 Pandemic In Middle East and Africa Country Markets
- ASTELLAS PHARMA INC.
- JOHNSON AND JOHNSON SERVICES, INC.
- LUYE PHARMA GROUP
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- NOVARTIS AG
- To understand the middle east and africa liposome drug delivery market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for middle east and africa liposome drug delivery market
- Efficiently plan m&a and partnership deals in liposome drug delivery market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form middle east and africa liposome drug delivery market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in middle east and africa region